Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
11/2003
11/13/2003WO2003093220A1 Process for preparing highly functionalized y-butyrolactams and y-amino acids
11/13/2003WO2003092670A1 Bombesin antagonists
11/13/2003WO2003092374A2 Pesticidal heterocycles
11/13/2003WO2002099077A3 Methods and compositions related to tagging of membrane surface proteins
11/13/2003WO2002098849A3 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer’s disease and similar diseases
11/13/2003WO2002083622A3 Novel aminophenyl ketone derivatives
11/13/2003WO2002032874A8 Substituted heterocyclic compounds for treating multidrug resistance
11/13/2003WO2002032868A8 2-substituted heterocyclic compounds and their use in treating multidrug resistance
11/13/2003US20030212279 Anticholesterol agents
11/13/2003US20030212140 Analgesics; central nervous system disorders
11/13/2003US20030212122 Purified racemic lasofoxifene and purified lasofoxifene D-tartrate and a method for effective purification of racemic lasofoxifene
11/13/2003US20030212113 Novel aromatic compounds and poly(oxyalkylene) containing aromatic compounds possessing antibacterial, antifungal or antitumor activity
11/13/2003US20030212081 Bicyclic heteroaromatic compounds useful as LH agonists
11/13/2003US20030212068 Antiinflammatory agents; antiallergens; antiarthritic agents
11/13/2003US20030212066 1-Sulfonyl pyrrolidine derivatives
11/13/2003US20030212012 Prevention labor contraction; urogenital disorders
11/13/2003US20030211999 Polypeptides containing gamma-amino acids
11/13/2003CA2485065A1 Semicarbazide derivatives for combating thromboembolic diseases
11/13/2003CA2484582A1 Bombesin antagonists
11/13/2003CA2483862A1 Process for the preparation of the amorphous form of atorvastatin calcium salt
11/13/2003CA2483830A1 Process for preparing highly functionalized y-butyrolactams and y-amino acids
11/13/2003CA2462645A1 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
11/12/2003EP1361212A1 Peptide derivatives as antithrombotic agents
11/12/2003EP1361210A2 Novel immunotherapeutic agents and their use in the reduction of cytokine levels
11/12/2003EP1360901A1 2,3-cyclic substituted derivatives of 3-hydroxyacrolein and 3-hydroxyacrylic acid as pesticides
11/12/2003EP1360176A1 Pyrrolecarboxamides for use as fungicides
11/12/2003EP1360170A1 Carboxylic amides, the production and use thereof as medicaments
11/12/2003EP1360167A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use
11/12/2003EP1206444B1 Compounds that inhibit tryptase activity
11/12/2003CN1455769A Cyclylamine sulfonamides as beta-3 adrenergic receptor agonists
11/12/2003CN1127503C (R)-2[3-(2-N-phthalic amino ethyl)-4,5-dihydro-5-isoxazolyl] -acezolyl] -acetic acid and its synthesis
11/12/2003CN1127483C Tert-butyl (3R,5R)-3, 5-dihydroxy-7-N-phthaloylimino heptanonate and its synthesis and use thereof
11/12/2003CN1127481C Method for recovering N-vinyl-2-pyrrolidone
11/11/2003US6646162 Compounds and compositions for delivering active agents
11/11/2003US6646149 Derivitives of spermine or its N12-t-butyl carbamate
11/11/2003US6646137 Non-peptide GnRH agents
11/11/2003US6646133 Hyperlipidemia and hypercholestrolemia.
11/11/2003US6646012 Central nervous system analgesic; hypotensive agents; antiarrhythmia agents; antidiabetic agents
11/11/2003US6646010 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/11/2003US6645999 Lactacystin analogs
11/11/2003US6645995 Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV
11/11/2003US6645958 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
11/11/2003US6645956 1-(5-(4-fluorobenzyl)furan-2-yl)-3-hydroxy-3-(1H-1,2,4-triazol-3 -yl)-propenone; viricides; AIDS treatment
11/11/2003US6645939 Substituted β-alanine derivatives as cell adhesion inhibitors
11/11/2003CA2264268C Novel peptide derivatives having thiazolyl-alanine residue
11/06/2003WO2003091232A2 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
11/06/2003WO2003091212A1 Cinnamic acid amides
11/06/2003WO2003091210A1 A new synthesis for the preparation of porphobilinogen and the compound as such as stabilized salt and intermediates thereof
11/06/2003WO2003091209A1 Process for producing 1-(lower alkyl)-3-hydroxypyrrolidine compound
11/06/2003WO2003091202A1 Diketohydrazine derivative compounds and drugs contaiing the compounds as the active ingredient
11/06/2003WO2003090678A2 Antileishmanial dinitroaniline sulfonamides with activity against parasite tubulin
11/06/2003WO2003066889A3 Assay for acytyltransferase or deacetylase activity
11/06/2003WO2003034900A3 Sterile, breathable patch for treating wound pain
11/06/2003WO2003014080A3 Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of levetiracetam and analogues
11/06/2003WO2002051983A3 Novel compounds and compositions as cathepsin inhibitors
11/06/2003US20030207935 For treating hypoxia protective, nootropic and neurodegenerative diseases (cerbral ischemia, Alzheimer's disease, and vascular dementia)
11/06/2003US20030207925 Methods of treatment with selective EP4 receptor agonists
11/06/2003US20030207922 Diketoacids useful as inhibitors of viral polymerases, in particular hepatitis C virus, RNA dependent RNA polymerase, hepatitis B virus polymerase and reverse transcriptase of human immunodeficiency virus
11/06/2003US20030207919 For treating, preventing, reducing inflammation, pain, fever,gastrointestinal disorders; decreasing gastrointestinal, renal and other toxicities resulting from use of nonsteroidal antiinflammatory drugs; multiplicity of compounds
11/06/2003US20030207894 1,4-Disubstituted benzenes as insecticides
11/06/2003US20030207889 Metaloenzyme and tumor necrosis factor-alpha converting enzyme inhibitors such as 2-(4-Methoxyphenylsulfonylmethyl)-5-phthalimido-pentanoic acid N-hydroxy amide, used for prophylaxis of degenerative diseases and cancer
11/06/2003US20030207861 Novel compounds as NS3-serine protease inhibitors of hepatitis C virus
11/06/2003US20030207823 Novel diabetes imaging probes
11/06/2003US20030207794 Compounds which are alpha -halogenoacryloyl distamycin derivatives of formula (I) wherein R1 is a bromine or chlorine atom; R2 is a distamycin or distamycin-like framework as set forth in the specification; or a pharmaceutically acceptable
11/06/2003CA2483725A1 Antileishmanial dinitroaniline sulfonamides with activity against parasite tubulin
11/06/2003CA2483155A1 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
11/05/2003EP1359144A1 Method for the preparation of bismaleimides
11/05/2003EP1358172A2 Amino ceramide-like compounds and therapeutic methods of use
11/05/2003EP1358155A1 Aromatic sulfonyl alpha-cycloamino hydroxamates and their use as mmp inhibitors
11/05/2003EP1358154A2 Pyrrolidine derivatives, their preparation and their use as inhibitors of neuraminidases
11/05/2003EP1212300B1 Azacycloalkanone serine protease inhibitors
11/05/2003EP1154996B1 Aroyl aminoacyl pyrroles for use in the treatment of neuropathic pain
11/05/2003EP1153006B1 Stabilised compositions of o- and n-vinyl compounds and the use of ammonium salts as stabilisers
11/05/2003CN1454086A High affinity small molecule C5A receptor modulators
11/05/2003CN1453268A Process for producing aziridine compound and N-vinyl amide
11/04/2003US6642392 Pyrrole derivatives
11/04/2003US6642391 Amycolatopsis culture product; antibiotic
11/04/2003US6642318 Polymerization process with living characteristics and polymers made therefrom
11/04/2003US6642267 Side effect reduction over opioid analgesics; analgesic and/or anxiolytic action
11/04/2003US6642266 EP4 receptor selective agonists in the treatment of osteoporosis
11/04/2003US6642255 Substituted carbocyclic or heterocyclic hydroxamic acid derivatives, e.g., (3R,4S)-N-hydroxy-1-methyl-3-(((4-((2-methyl-4 -quinolinyl)methoxylphenyl)sulfonyl)methyl)-4-piperidinecarboxamide
11/04/2003US6642252 Anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer.
11/04/2003US6642247 Treting anxiety, stress, depression, trauma, Alzheimer's mediated memory loss, epilepsy, arterial blood pressure disorders, obesity, acute pain, chronic pain, Na+ excretion, control of water balance, and symptoms associated with drug
11/04/2003US6642218 (5Z,7E,22E)-(1S,3R,24R)-25-(5-Propyloxazol-2-yl)-26,27-cyclo -9,10-secocholesta-5,7,10(19), 22-tetraene-1,3,24-triol for treatment of diseases characterized by hyperproliferation and deficient cell differentiation
11/04/2003US6642216 Osteoporosis, periodontal diseases
11/04/2003CA2266006C Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
11/04/2003CA2257322C Thiazole derivatives
10/2003
10/30/2003WO2003089409A1 Compounds having affinity at 5ht2c receptor and use thereof in therapy
10/30/2003WO2003088909A2 Methods for modulating phototoxicity
10/30/2003WO2003066579A3 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
10/30/2003WO2003063796A3 Heterocyclic arylsulfonamidobenzylic compounds
10/30/2003WO2003055857A8 A process for synthesis of heterocyclic aminoalkyl benzamides
10/30/2003WO2002069901A3 Cathepsin cysteine protease inhibitors
10/30/2003US20030204098 Producing the aziridines and the N-vinyl amides industrially advantageously by preventing a solid substance from forming and depositing in the decompressing system which is connected to the purifying step (vacuum distillation)
10/30/2003US20030204085 3, 4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor antagonists
10/30/2003US20030204034 Forming a mixture of one or more monomers, at least one free radical source and a control agent and subjecting mixture to polymerization
10/30/2003US20030203975 Such as complex of amino acid/peptide and 1-(2-hydroxyethylamino)anthracene-9,10-dione
10/30/2003US20030203936 Aminopyrrolidine sulfonamides as serine protease inhibitors
10/30/2003US20030203906 Novel substituted diamine derivatives useful as motlin antagonists
10/30/2003US20030203895 Pyrrolylalkylidene-hydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands
1 ... 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 ... 404